Pharnext competitorsClear all

Pharnext's top competitors include MyoKardia, Otonomy, Shire and Athersys.
Pharnext
Pharnext
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Otonomy
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Shire
Shire
Shire is a specialty biopharmaceutical company.
Athersys
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Founding Date
Founding Date
2007
Founding Date
2012
Founding Date
2008
Founding Date
1986
Founding Date
1995
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Issy-les-Moulineaux, FR HQ
Locations
South San Francisco, US HQ
Locations
San Diego, US HQ
Locations
Dublin, IE HQ
The Rocks, AU
Wien, AT
Bruxelles, BE
Sofia, BG
see more
Locations
Cleveland, US HQ
Canton, US
Employees
Employees
4319% increase
Employees
1024% increase
Employees
498% decrease
Employees
23,044
Employees
7514% increase
Valuation ($)
Valuation ($)
123.1 m
Valuation ($)
2.2 b
Valuation ($)
73.6 m
Valuation ($)
54.8 b
Valuation ($)
241.1 m
Twitter followers
Twitter followers
811
Twitter followers
653
Twitter followers
233
Twitter followers
7.7 k
Twitter followers
1.2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
50
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
6
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
2.4
Average likes per tweet (last 30 days)
13.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
12.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
1335066
Alexa Website Rank
378335
Alexa Website Rank
318925
Alexa Website Rank
333836
Alexa Website Rank
609659

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$33.6m (FY, 2018)
Revenue (est.)
$745k (FY, 2018)
Revenue (est.)
£43m (FY, 2018)
Revenue (est.)
$24.3m (FY, 2018)
Net income
Net income
N/A
Net income
($67.7m) (FY, 2018)
Net income
($50.4m) (FY, 2018)
Net income
£3.4m (FY, 2018)
Net income
($24.3m) (FY, 2018)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
4 (FY, 2017)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
21 (FY, 2016)
Patents Issued
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
88 (FY, 2016)
Patents Issued
N/A
Patents Issued
200 (FY, 2016)
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2017)
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
7 (FY, 2017)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
1 (FY, 2017)
Phase II Trials Products
2 (FY, 2016)
Phase II Trials Products
10 (FY, 2017)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
15 (FY, 2017)
Phase III Trials Products
N/A
Preclinical Phase Products
Preclinical Phase Products
N/A
Preclinical Phase Products
3 (FY, 2017)
Preclinical Phase Products
1 (FY, 2016)
Preclinical Phase Products
35 (FY, 2017)
Preclinical Phase Products
N/A

Funding

Total funding raised
Total funding raised
$ 10.6m
Total funding raised
$ 98m
Total funding raised
$ 153.4m
Total funding raised
N/A
Total funding raised
$ 9m
For sources of this data, please see the company profile

View company profiles

MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Otonomy
HQ
San Diego, US
Employees
49↓ 8% decrease

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

View company
Shire
HQ
Dublin, IE
Employees
23,044

Shire is a specialty biopharmaceutical company.

View company
Athersys
HQ
Cleveland, US
Employees
75↑ 14% increase

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company